The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case
Background. Combination therapy with two antiplatelet agents (ticagrelor or clopidogrel plus acetylsalicylic acid) and a high dose statin is recommended in accordance with clinical guidelines for patients undergoing acute coronary syndrome and coronary intervention. Combined therapeutic regimens hav...
Main Authors: | O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2022-11-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2827 |
Similar Items
-
Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
by: Keiki Sakurama, et al.
Published: (2023-04-01) -
Rosuvastatin-Induced reversible rhabdomyolysis
by: Sangeeta Pradhan, et al.
Published: (2023-01-01) -
The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01) -
Fatal Acute Diclofenac-Induced Rhabdomyolysis in A Pediatric Patient
by: Ahmet Güzel, et al.
Published: (2011-03-01) -
Olanzapine induced hyponatremia and rhabdomyolysis
by: N'joumi Younes, et al.
Published: (2023-02-01)